ArticleOman medical journal2018
Investigation of Class I, II, and III Integrons Among
Article in Oman medical journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.
- Prevalence of Integrons and Antibiotic Resistance Pattern inEthiopian journal of health sciences · 2019Pooled it
- Molecular Characterization and Clonal Analysis of Carbapenem-ResistantBioMed research international · 2026Article
- Prevalence of Antibiotic Resistance Determinants in Carbapenem-ResistantInternational journal of molecular and cellular medicine · 2025Article
- Identification of blaBMC research notes · 2024Article
- Isolation and Identification of Effective Probiotics on Drug-ResistantThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2024Article
- The Resistome of ESKAPEE Pathogens in Untreated and Treated Wastewater: A Polish Case Study.Biomolecules · 2022Article
- Distribution and Molecular Characterization of Functional Class 2 Integrons in ClinicalInfection and drug resistance · 2022Article
- Molecular Characterization of Carbapenem-ResistantInfection and drug resistance · 2022Review
- Genotyping and molecular characterization of clinicalPathogens and global health · 2020Article
- Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2020Review
- Prevalence of class 1 integron inTropical medicine and health · 2020Article
- Molecular epidemiology of colistin-resistantIranian journal of basic medical sciences · 2019Article
- Investigation of antimicrobial susceptibility, class I and II integrons among Pseudomonas aeruginosa isolates from hospitalized patients in Isfahan, Iran.BMC research notes · 2018Article
- Antibiotic Resistance Pattern ofSaudi journal of medicine & medical sciencesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study aimed to determine the prevalence of class I, II, and III integrons among clinical
methodsThis cross-sectional study was conducted at two teaching hospitals in Isfahan, Iran, from October 2015 to October 2016. A total of 147 non-duplicate
resultsOut of 147 confirmed
conclusionOur results show a high prevalence of classes I and II integrons which may play a key role in the acquisition of MDR and XDR phenotype among
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.